2016

1. Identification of novel pathways linking epithelial-to-mesenchymal transition with resistance to HER2-targeted therapy

   Oncotarget, Vol. 7, Núm. 10, pp. 11539-11552

2. Use of a genetically engineered mouse model as a preclinical tool for HER2 breast cancer

   DMM Disease Models and Mechanisms, Vol. 9, Núm. 2, pp. 131-140